- InstantOn purchase
- Full bookAll chapters
- Any devicePC, tablet, phone
- SecureSSL checkout
Current Advances in Osteosarcoma
by Classics Books & Gifts
Lowest price online, guaranteed. One-time payment, no subscription.
Download link emailed instantly after payment, 24/7
Your download link is sent to the email you enter. Double-check it before completing your order.
File issue? We replace it or refund you, no questions asked.
You'll receive a download link by email immediately after checkout.
Send us the book cover via live chat and we'll request it for you. Typical response time: 10 minutes.
What's inside
Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward.
About the Author
Eugenie S. Kleinerman, M.D. is Professor and Head of the Division of Pediatrics, the first women Division Head at MD Anderson Cancer Center. She is board certified in pediatrics, holds the Mosbacher Pediatrics Chair and is also a Professor of Cancer Biology. Dr. Kleinerman is internationally recognized for her scientific and clinical expertise in sarcomas, particularly osteosarcoma. She pioneered the use of a unique immunotherapy agent liposome-encapsulated MTP-PE, for children with unresponsive relapsed osteosarcoma lung metastases. Dr. Kleinerman has served on numerous NCI study sections and was a prior member of an FDA advisory panel. She has authored over 177 articles and 21 book chapters and has received over 2900 citations. In 2006, her achievements were recognized by her alma mater, Duke University Medical Center, where she received the Distinguished Medical Alumnus Award. She is the 2009 recipient of the Faculty Achievement Award in Clinical Research.
| Author | Eugenie S. Kleinerman, M.D. (Editor) |
| ISBN-13 | 9783319048437 |
| Publisher | Springer-Verlag New York, LLC |
| Publication Date | 06/12/2014 |
| Series | Advances in Experimental Medicine and Biology |
| Page Count | 359 pages |
From checkout to chapter one in seconds
Check out securely
Pay by card or wallet. Use an email address you can access right now.
Get your link
Your download link arrives by email the moment your payment clears, 24/7.
Read anywhere
Open it on your laptop, tablet or phone. Save it and keep it.
Smarter than paying full price
Authorised by publisher: licensed copy, never pirated.
Less than Amazon Kindle, with our lowest-price guarantee.
Delivered the moment your payment clears, day or night.
Complete edition: every chapter, no missing pages.
Good to know
How do I receive my ebook?
Right after checkout we email you a download link. Check your spam folder if it doesn't arrive within a few minutes.
Which devices can I read it on?
Any computer, tablet or phone. PDF opens in any browser or free reader app.
I entered the wrong email. What now?
Contact us via live chat with your order number and we'll resend the link to the right address.
What if there's a problem with the file?
We'll replace it or refund you within 30 days, no questions asked.